In the name of of Allah the Merciful

Hugo and Russell's Pharmaceutical Microbiology

9th Edition, Brendan F. Gilmore, Stephen P. Denyer, 1119434491, 978-1119434498, 9781119434498, B0BRTJ9KL8

100,000 Toman
The desired product is not available.

English | 2023 | PDF | 20 MB | 579 Pages

  • {{value}}
کمی صبر کنید...

Discover the very latest developments in pharmaceutical microbiology in the 9th edition of this popular textbook

Microbiology  is one of the essential pharmaceutical sciences upon which the study  and practice of pharmacy is built. It has a bearing on all aspects of  the manufacture of medicines and sterile products, from their design and  development to their delivery as quality products. Few interventions  are more central to modern medicine than the treatment of infection,  where antibiosis, vaccination and hygienic practices have essential  roles to play. The COVID-19 pandemic, the appearance of new pathogens  and the rise of antibiotic resistance have demonstrated most completely  the need for pharmaceutical practitioners, researchers and industrial  scientists to be fully conversant with this field. 

The 9th edition of Hugo and Russell’s Pharmaceutical Microbiology has been updated to meet this need. Having long served as the sole  comprehensive textbook covering this subject, it has now been adapted to  a critical new period in the advancement of medical and pharmaceutical  research and development. Its experienced editors have incorporated  contributions from subject experts and created a text which will serve  the next generation of pharmacy students, pharmaceutical industry  scientists and researchers. 

In this ninth edition of Hugo and Russell’s Pharmaceutical Microbiology, readers will find: 

  •  A mix of established and new authors bringing practical and research experience to their chapters 
  •  Material covering the fundamentals of microbiology, microbial behavior and laboratory investigation
  •  Revised chapters incorporating new material on microbe-host  interactions, antibiotic resistance, emerging pathogens, public health  microbiology, healthcare-associated infection and pharmaceutical  manufacture
  •  Emerging understandings from the COVID-19 pandemic on infection prevention and control and vaccine development
  •  Practitioners providing their insights on clinical practice and pharmaceutical production